- May 18, 2017
6:45 pm - 9:00 pm
Cardiologists, Lipidologists, and other healthcare professionals responsible for the diagnosis, treatment or management of patients with dyslipidemia.
- Review advances in LDL-C science and the role of LDL-C in CVD prevention
- Understand the current ACC/AHA/ESC/NLA guidelines for the management of patients with dyslipidemia.
- Analyze extended CVD Outcomes clinical trial data for PCSK9 inhibitor therapeutics.
- Apply newer scientific knowledge and data into personalized treatment plans for patients with statin intolerance, familial hypercholesterolemia, and dyslipidemia patients not at LDL-C goal.